Solara Active Pharma Sciences
SOLARANSE

Solara Active Pharma Sciences

₹503.70-4.90 (0.96%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
501.00
Today’s high
519.50
52 week low
422.00
52 week high
734.40
Open price
509.10
Previous close
508.60
Live volume
58,833
Lower circuit
403.00
Upper circuit
604.40

Fundamentals

Market Cap
₹1,854Cr
ROE
0.51%
P/E Ratio(TTM)
--
EPS(TTM)
-5.28
P/B Ratio
1.49
Dividend Yield
0.00%
Industry P/E
34.42
Book Value
344.59
Debt to Equity
0.51
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹349
+11.14%
Profit (Cr)
-₹17.43
-72.57%
-25039.06156.3351.6
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+16%
3Y CAGR0%
Profit growthValue
3Y CAGR+26%

About

Solara Active Pharma Sciences Limited is a pure-play API manufacturer, offering a wide range of APIs and contract manufacturing services.;
CEO/MD
Poorvank Purohit
Founded in
2017
NSE symbol
SOLARA

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
42.00%
Retail And Others
40.05%
Foreign Institutions
14.20%
Other Domestic Institutions
2.57%
Mutual Funds
1.18%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹874.90
+3.05 (0.35%)
L
    H
    4,968.5535.254.55
    ₹377.50
    +15.20 (4.20%)
    L
      H
      3,946.1882.4914.92
      ₹404.05
      +2.05 (0.51%)
      L
        H
        3,756.3841.915.15
        Orchid PharmaORCHPHARMA
        ₹695.55
        -13.10 (1.85%)
        L
          H
          3,589.90190.272.82
          Livesquawk
          Solara Active Pharma faces ₹161.9 Cr tax demand for AY20 from Thane authority. The company plans to appeal and expects no significant operational impact.
          2026
          15
          May
          Quarterly & Annual Result
          Upcoming
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2025
          5
          Nov
          Quarterly Result
          Release date
          25
          Jul
          Quarterly Result
          Release date
          2024

          15
          May
          Rights Entitlement
          Ex date
          1:3
          Ratio

          1 rights eligible for every 3 existing shares held
          Ratio1:3
          Offer price₹375.00
          Ex date15 May ‘24
          Record date15 May ‘24
          Announcement date9 May ‘24
          Events calendar
          View upcoming events in other stocks